Human MGLL/HU-K5/HUK5 ORF/cDNA clone-Mammalian (Non-Viral Vector) plasmid (NM_001003794.3)
Cat. No.: pGMPC001242
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human MGLL/HU-K5/HUK5 Non-Viral expression plasmid (overexpression vector) for mouse MGLL overexpression in unique cell transient transfection and stable cell line development.
Go to
MGLL/MAGL/MGLL/HU-K5 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMPC001242 |
| Gene Name | MGLL |
| Accession Number | NM_001003794.3 |
| Gene ID | 11343 |
| Species | Human |
| Product Type | Mammalian (Non-Viral Vector) plasmid (overexpression) |
| Insert Length | 912 bp |
| Gene Alias | HU-K5,HUK5,MAGL,MGL |
| Fluorescent Reporter | EGFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCCAGAGGAAAGTTCCCCCAGGCGGACCCCGCAGAGCATTCCCTACCAGGACCTCCCTCACCTGGTCAATGCAGACGGACAGTACCTCTTCTGCAGGTACTGGAAACCCACAGGCACACCCAAGGCCCTCATCTTTGTGTCCCATGGAGCCGGAGAGCACAGTGGCCGCTATGAAGAGCTGGCTCGGATGCTGATGGGGCTGGACCTGCTGGTGTTCGCCCACGACCATGTTGGCCACGGACAGAGCGAAGGGGAGAGGATGGTAGTGTCTGACTTCCACGTTTTCGTCAGGGATGTGTTGCAGCATGTGGATTCCATGCAGAAAGACTACCCTGGGCTTCCTGTCTTCCTTCTGGGCCACTCCATGGGAGGCGCCATCGCCATCCTCACGGCCGCAGAGAGGCCGGGCCACTTCGCCGGCATGGTACTCATTTCGCCTCTGGTTCTTGCCAATCCTGAATCTGCAACAACTTTCAAGGTCCTTGCTGCGAAAGTGCTCAACCTTGTGCTGCCAAACTTGTCCCTCGGGCCCATCGACTCCAGCGTGCTCTCTCGGAATAAGACAGAGGTCGACATTTATAACTCAGACCCCCTGATCTGCCGGGCAGGGCTGAAGGTGTGCTTCGGCATCCAACTGCTGAATGCCGTCTCACGGGTGGAGCGCGCCCTCCCCAAGCTGACTGTGCCCTTCCTGCTGCTCCAGGGCTCTGCCGATCGCCTATGTGACAGCAAAGGGGCCTACCTGCTCATGGAGTTAGCCAAGAGCCAGGACAAGACTCTCAAGATTTATGAAGGTGCCTACCATGTTCTCCACAAGGAGCTTCCTGAAGTCACCAACTCCGTCTTCCATGAAATAAACATGTGGGTCTCTCAAAGGACAGCCACGGCAGGAACTGCGTCCCCACCCTGA |
| ORF Protein Sequence | MPEESSPRRTPQSIPYQDLPHLVNADGQYLFCRYWKPTGTPKALIFVSHGAGEHSGRYEELARMLMGLDLLVFAHDHVGHGQSEGERMVVSDFHVFVRDVLQHVDSMQKDYPGLPVFLLGHSMGGAIAILTAAERPGHFAGMVLISPLVLANPESATTFKVLAAKVLNLVLPNLSLGPIDSSVLSRNKTEVDIYNSDPLICRAGLKVCFGIQLLNAVSRVERALPKLTVPFLLLQGSADRLCDSKGAYLLMELAKSQDKTLKIYEGAYHVLHKELPEVTNSVFHEINMWVSQRTATAGTASPP |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T18664-Ab | Anti-MAGL monoclonal antibody |
| Target Antigen | GM-Tg-g-T18664-Ag | MAGL/MGLL protein |
| ORF Viral Vector | pGMLP002140 | Human MGLL Lentivirus plasmid |
| ORF Viral Vector | pGMLP004052 | Human MGLL Lentivirus plasmid |
| ORF Viral Vector | pGMPC001242 | Human MGLL Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002140 | Human MGLL Lentivirus particle |
| ORF Viral Vector | vGMLP004052 | Human MGLL Lentivirus particle |
Target information
| Target ID | GM-T18664 |
| Target Name | MGLL/MAGL |
|
Gene Group Identifier (Target Gene ID in Homo species) |
11343 |
| Gene ID |
100053785 (Equus caballus), 100429242 (Macaca mulatta), 101089928 (Felis catus), 11343 (Homo sapiens) 23945 (Mus musculus), 29254 (Rattus norvegicus), 476511 (Canis lupus familiaris), 505290 (Bos taurus) |
| Gene Symbols & Synonyms | MGLL,Mgll,MGL,HUK5,MAGL,HU-K5,Mgl,Magl |
| Target Alternative Names | HU-K5,HUK5,Lysophospholipase homolog,Lysophospholipase-like,MAGL,MGL,MGLL,Magl,Mgl,Mgll,Monoacylglycerol lipase (MAGL),Monoglyceride lipase |
| Uniprot Accession |
O35678,Q8R431,Q99685
Additional SwissProt Accessions: Q99685,O35678,Q8R431 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | Metabolic pathways, Regulation of lipolysis in adipocytes |
| Gene Ensembl | ENSECAG00000007658, ENSMMUG00000000168, ENSG00000074416, ENSMUSG00000033174, ENSCAFG00845017684, ENSBTAG00000018248 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


